Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
PathGroup United States | 13 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
RB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Multi-Cancer + RNA Panel Invitae United States | 143 | 63 |
|
PathGroup United States | 73 | 505 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States | 23 | 3 |
|
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States | 25 | 3 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 147 | 18 |
|
Variant Resolution Test for MelanomaNext® (+RNAinsight®) Ambry Genetics United States | 40 | 3 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 95 | 71 |
|
PrimBio Research Institute United States | 60 | 50 |
|
RB1 gene sequence and deletion/duplication Ambry Genetics United States | 4 | 1 |
|
Ambry Genetics United States | 40 | 9 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.